Hereditary nonpolyposis colorectal cancer

HERA Foundation Announces 2012 Community Grant Recipients

DENVER – August 16, 2012 – The HERA Women’s Cancer Foundation, a nationally recognized ovarian cancer nonprofit, awarded its 2012 Community Grants to four organizations across the country working to improve quality of life for women with ovarian cancer or raise awareness of the disease in novel and unusual ways.

Registration Opens for HERA Women’s Cancer Foundation 7th Annual Climb4Life Metro DC

DENVER – June 7, 2012 – The HERA Women’s Cancer Foundation, a nationally recognized ovarian cancer nonprofit, has opened registration for its 7th Annual Climb4Life Metro DC, taking place July 13-15. The weekend event features rock climbing, hiking and biking in Carderock, Md. and Great Falls, Va., as well as other activities for empowering women and their families while raising awareness of the signs and symptoms of ovarian cancer.

Dendrion ($DNDN): Its Complex but Gold is Gone so is Platinium Ahead ?

A very significant event in the world of cell therapy occurred this week when news came that Mitch Gold, CEO of Dendreon (NASDAQ: DNDN) has left the company. Wall Street analysts reacted positively and the stock was up modestly on the news and has since settled back. Dendreon has been the shining example of what's possible in the cell therapy space until the company seemed to over-inflate expectations, and over-ramped manufacturing.

Welcome to ocam.org.uk, the central ovarian cancer charity information portal.

All four national ovarian cancer charities are working together for the first time during Ovarian Cancer Awareness Month (March 2012) to build awareness of signs and symptoms of ovarian cancer.

Syndicate content